Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials.
about
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemiaGenetic engineering with T cell receptorsAdoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlookIn vivo imaging of therapy-induced anti-cancer immune responses in humans.T-cell receptor gene therapy--ready to go viral?Cish actively silences TCR signaling in CD8+ T cells to maintain tumor toleranceHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferEngineered T cells for cancer treatmentThe human application of gene therapy to re-program T-cell specificity using chimeric antigen receptorsClinical application of genetically modified T cells in cancer therapy.Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancer.Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell ReceptorsPhenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLAAn optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells.Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Domain-swapped T cell receptors improve the safety of TCR gene therapy.T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.Biomarkers in T cell therapy clinical trials.Challenges in T cell receptor gene therapy.Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation.Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies.Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptorsAdoptive cellular therapy: a race to the finish line.Driving gene-engineered T cell immunotherapy of cancer.T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PETUnbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.Hitting the Target: How T Cells Detect and Eliminate Tumors.A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.Current Status of Gene Engineering Cell Therapeutics.The mutational status of p53 can influence its recognition by human T-cells.A humanized TCR retaining authentic specificity and affinity conferred potent anti-tumor cytotoxicity.
P2860
Q24632975-81DD56A6-53BC-460D-8D64-53E51DC74573Q26995677-06319782-42EF-443E-A5FD-EBBB2711F286Q27004178-46970BDB-F9A0-4374-A32C-439A38F9F29CQ27693338-F27956C4-01CE-442C-A060-75B55B3256E3Q28081611-D4ADEF03-B63B-49CC-A6BA-42D887382960Q28269352-E9863B11-BF46-4CFB-B483-49AF00AD2674Q28727481-F4E1856A-2BD2-4496-B903-3DA10C089F82Q33578792-AA79A3F7-C221-4CA4-83B3-823653BE9F9DQ34309388-9E533073-0C79-4AC0-8E46-D10F69BF6102Q34511646-5F6D3A87-90E2-4CFF-B533-5C7123D67037Q34592273-60806D69-1330-4D9F-AB4B-BD17F7BB8E69Q35135031-E7892572-A1D0-4728-9DC6-70A52A24A2C1Q35960524-F8590719-6C17-4DE3-ADF2-A7E6A1648696Q36026142-49531D89-F888-4A4F-AA25-A06638537F41Q36480611-C6589EE8-96CE-4773-9F4A-D35B6AD25E61Q36637039-4E1C4C40-F313-41FF-A715-9DD7ACC4569CQ37012701-D0F654A5-C284-4175-925C-D9E6968FC2C5Q37225251-B6681FC6-B202-40DA-AE9C-7362D153B78BQ37257207-8FA3D1B1-ABE8-474E-8A12-4CB72DEFBE1AQ37401728-C4424EAD-C8E3-4AFB-AFE8-A20574E394AAQ37466219-21ED6B7A-072D-444A-AF06-3F9ECF000586Q37587362-5FDD0F61-CCA4-46FF-ACD8-1D4752DC701BQ37592957-916079C8-E1CB-480A-84FE-0C604544DE13Q37919589-F91A2D3D-96F5-41D2-9E17-59C5EE6FA639Q38011650-CF1139F2-E788-4F86-8863-649C2E533B50Q38170501-AAB99ED3-DAD2-43D8-9BCC-409231CADB16Q38289029-2E22F112-A0B5-4371-881E-888861E93BD8Q38291751-86E3B76D-D566-47D2-A157-6512BFFE2B5DQ38391528-99DEDE72-76DE-40BD-A4CD-CCA161F6A911Q38777742-228DDE8E-1194-42B1-930C-81A2BFC42717Q38820650-072F882B-C9B9-4449-9EDB-E68EFFAFDA40Q39037477-E49F9E8C-7307-46FA-937E-92A079CBC7ABQ41069577-756C1C7F-23A7-43CE-B1CB-3CFBA80036AEQ41114267-32587827-B69A-4DAD-942E-9A14C11D7C87Q45872498-C01ADBB5-19C3-4D60-8BA0-D1AEECDA3F06Q47222791-D7AC25DA-4F67-472F-9342-B4EC5C28DD6FQ47549907-C4F3DD97-BF44-49EB-AE6F-13C3E1CDF87AQ49829282-75C942D1-50B8-422E-8E38-F6CC5E68F6C6Q50999703-DBC55661-04AC-42A7-A295-BF493E8720B0Q52323967-8DF8F646-7E74-414A-8369-4392997CE947
P2860
Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of human anti-muri ...... ed in TCR gene therapy trials.
@ast
Development of human anti-muri ...... ed in TCR gene therapy trials.
@en
Development of human anti-muri ...... ed in TCR gene therapy trials.
@nl
type
label
Development of human anti-muri ...... ed in TCR gene therapy trials.
@ast
Development of human anti-muri ...... ed in TCR gene therapy trials.
@en
Development of human anti-muri ...... ed in TCR gene therapy trials.
@nl
prefLabel
Development of human anti-muri ...... ed in TCR gene therapy trials.
@ast
Development of human anti-muri ...... ed in TCR gene therapy trials.
@en
Development of human anti-muri ...... ed in TCR gene therapy trials.
@nl
P2093
P2860
P921
P1476
Development of human anti-muri ...... ed in TCR gene therapy trials.
@en
P2093
Cor H J Lamers
Jeremy L Davis
Marc R Theoret
Richard A Morgan
Steven A Rosenberg
Zhili Zheng
P2860
P304
P356
10.1158/1078-0432.CCR-10-1280
P407
P577
2010-12-01T00:00:00Z